CXCR7 GPCR insurmountable antagonist

target engagement in rodent, 61% F in dog

from 300k HTS vs. _-arrestin recruitment, opt.

J. Med. Chem., Dec. 14, 2020

Idorsia Pharma (Actelion), Allschwil, CH

Idorsia/Actelion CXCR7 GPCR insurmountable antagonist


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks